Free Virtual Consultations. Corona Virus Related Cases Click Here.

Driver Killed After Crashing Into Gas Station on E. Vineyard Avenue

SUV Involved in Fatal Oxnard Accident

Fatal Accident 5

Oxnard, CA (February 15, 2020) – One person was killed after crashing into a gas station in Oxnard. The fatal accident occurred on the afternoon of February 15 on E. Vineyard Avenue. 

An SUV crashed into the price sign at 76 Gas, located at 3402 E. Vineyard Avenue. The impact knocked over the sign. Emergency crews found a person lying outside the vehicle. The driver died at the accident scene. 

Our heartfelt condolences go out to the friends and loved ones of the victim.



January 30, 2020

Nathan Martin Killed in Crash on East Third Street

Big Rig Turns in Front of Police Officer’s Motorcycle in Fatal Oxnard Acciden...

February 4, 2020

Man Killed in Pedestrian Crash at Pacific Coast Highway and Caspian Avenue

Victim Hit by 2 Vehicles in Fatal Long Beach Accident...

December 4, 2019

Man Killed in Hit and Run Crash on Golden State Boulevard

Victim Dragged Several Hundred Yards in Fatal Selma Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.